Bausch + Lomb Corp (BLCO)vsWest Pharmaceutical Services Inc (WST)
BLCO
Bausch + Lomb Corp
$16.80
-0.30%
HEALTHCARE · Cap: $6.02B
WST
West Pharmaceutical Services Inc
$361.78
-0.15%
HEALTHCARE · Cap: $25.50B
Smart Verdict
WallStSmart Research — data-driven comparison
Bausch + Lomb Corp generates 60% more annual revenue ($5.32B vs $3.33B). WST leads profitability with a 17.0% profit margin vs -3.2%. BLCO appears more attractively valued with a PEG of 0.89. WST earns a higher WallStSmart Score of 61/100 (C+).
BLCO
Hold45
out of 100
Grade: D+
WST
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-76.3%
Fair Value
$9.66
Current Price
$16.80
$7.14 premium
Margin of Safety
-45.7%
Fair Value
$168.92
Current Price
$361.78
$192.86 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Growing faster than its price suggests
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Strong operational efficiency at 22.5%
Areas to Watch
Weak financial health signals
ROE of -3.4% — below average capital efficiency
Earnings declined 88.6%
Distress zone — elevated risk
Trading at 8.5x book value
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : BLCO
The strongest argument for BLCO centers on Price/Book, PEG Ratio. PEG of 0.89 suggests the stock is reasonably priced for its growth.
Bull Case : WST
The strongest argument for WST centers on Altman Z-Score, Debt/Equity, Operating Margin. Profitability is solid with margins at 17.0% and operating margin at 22.5%. Revenue growth of 13.8% demonstrates continued momentum.
Bear Case : BLCO
The primary concerns for BLCO are Piotroski F-Score, Return on Equity, EPS Growth.
Bear Case : WST
The primary concerns for WST are Price/Book, PEG Ratio, P/E Ratio. A P/E of 46.3x leaves little room for execution misses.
Key Dynamics to Monitor
BLCO profiles as a turnaround stock while WST is a mature play — different risk/reward profiles.
WST carries more volatility with a beta of 1.14 — expect wider price swings.
WST is growing revenue faster at 13.8% — sustainability is the question.
BLCO generates stronger free cash flow (82M), providing more financial flexibility.
Bottom Line
WST scores higher overall (61/100 vs 45/100), backed by strong 17.0% margins and 13.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Bausch + Lomb Corp
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Bausch Lomb Corporation is an eye health company in Canada and internationally. The company is headquartered in Vaughan, Canada.
Visit Website →West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?